Perfect StormFirstly, I want to acknowledge DrHoliday's analysis as excellent. Wuxi would definitely have interest in ICO and I have played this same analysis out in my head before. Now, on to the great news released before the long weekend and official end of "the summer months". ICO is releasing additional data at the upcoming Investor conference. The data which will be released at the conference would attract new eyes one would think. As DrHoliday mentioned, there will be companies trying to buyout ICO with such a small Market Cap at $8M. Well, that market cap is about to go up I believe. The gap down from 2014 is about to close and anyone who can read between the lines will view anything below $0.30 as a good entry point. With Phase I complete the cash burn rate slows significantly, allowing management to find the best value for shareholders in advancing Oral Amp B to Phase II. If an entity tries a takeover, what is considered fair? $100M, $200M or $500M? With the assets in the pipeline, a Big Pharma company may view a $500M investment as worthy when it will generate annual revenues of $1B+ with positive advancement of Oral Amp B to market. The chances of this happening are pretty high considering it is a drug that already has been in use for the last 50 year's and the company has just succeeded in delivery superiority with no toxicity. There is a lot to like about holding shares in this company and the management is delivering in a timely manner. All in all, I don't foresee major dilution coming while the company listens to prospective offers from potential financiers. What do you guys think? GLTA